PLoS ONE (Jan 2023)

D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia.

  • Thanawat Rattanathammethee,
  • Kawin Munsamai,
  • Teerachat Punnachet,
  • Nonthakorn Hantrakun,
  • Pokpong Piriyakhuntorn,
  • Sasinee Hantrakool,
  • Chatree Chai-Adisaksopha,
  • Ekarat Rattarittamrong,
  • Adisak Tantiworawit,
  • Lalita Norasetthada

DOI
https://doi.org/10.1371/journal.pone.0286089
Journal volume & issue
Vol. 18, no. 5
p. e0286089

Abstract

Read online

IntroductionThis study aimed to evaluate the performance of the D-index, a calculated measure of neutropenic burden, in predicting the risk of invasive fungal infections (IFIs) in acute myeloid leukemia (AML) patients.MethodsA retrospective study of adult AML patients who received the first induction chemotherapy and developed febrile neutropenia was conducted. Clinical characteristics, laboratory data, and the calculation of the D-index and cumulative D-index (c-D-index) were collected and analyzed between patients with and without IFIs.ResultsA total of 101 patients were included, with 16 (15.8%) patients who developed IFIs. Clinical characteristics, antifungal prophylaxis, and AML cytogenetic risk were similar between patients with or without IFIs. The results showed that the D-index and c-D-index were more effective in predicting IFIs than the duration of neutropenia. With the D-index cutoff of 7083, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 81.3%, 83.5%, 48.2%, and 95.9%, respectively. c-D-index at 5625 revealed sensitivity, specificity, PPV, and NPV for IFIs of 68.8%, 68.2%, 28.9%, and 92.1%, respectively. Using this cutoff of c-D-index, patients without IFIs were overtreated with an antifungal regimen in 45 (52.9%) cases.ConclusionThe D-index and c-D-index were helpful indicators for defining the risk of IFIs in AML patients with febrile neutropenia.